Cornerstone Robotics and Medtronic Expand Global Surgical Robotics Partnership with US$700 Million Investment

Cornerstone Robotics, an innovative surgical robotics company founded and headquartered in Hong Kong, today hosted the inaugural Surgical Futures Forum at ...

November 11, 2026 | Wednesday | News
Boehringer Ingelheim and Sino Biopharmaceutical Sign Potential US$7.36 Billion Oncology Licensing Deal

Partnership provides opportunities to further expand Boehringer Ingelheim’s portfolio of antibody-drug conjugates (ADCs) and T-cell engagers (TcEs)...

November 05, 2026 | Thursday | News
China Medical System Secures Singapore Approval for Lumirix Cream to Treat Vitiligo

China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Rxilient Medical received ...

November 05, 2026 | Thursday | News
HUTCHMED and AstraZeneca Secure Regulatory Review in Europe and Japan for ORPATHYS and TAGRISSO Lung Cancer Combination

HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) announces that regulatory filings for ORPATHYS® (savolitinib) in combinati...

November 03, 2026 | Tuesday | News
HighTide Therapeutics Reports Positive Preclinical Results for HTD1801 in Polycystic Kidney Disease

HighTide Therapeutics, Inc. (02511.HK), an innovative biopharmaceutical company specializing in the development of multifunctional, multi-targeted therapie...

October 27, 2026 | Tuesday | News
Grünenthal and DKSH Expand Asia-Pacific Partnership to Broaden Access to Pain Medicines

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading pr...

September 29, 2026 | Tuesday | News
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered Rentosertib for IPF

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced that it has dosed the first patien...

September 11, 2026 | Friday | News
HUTCHMED and GSK Enter Exclusive Global License Agreement for Novel KRAS-Targeted Cancer Therapy

HUTCHMED (China) Limited (“HUTCHMED”) announces that its subsidiary, HUTCHMED Limited, has entered into an exclusive development and license ...

September 04, 2026 | Friday | News
Ascletis Selected Oral ASC30 and ASC48 Combination for Obesity Clinical Development

ASC48 is a potentially first-in-class oral small molecule GIPR agonist. - ASC48 demonstrated an EC50 of 1 pM in the hGIPR cAMP activation assay, exhibit...

July 17, 2026 | Friday | News
Aligos Receives $25 Million Upfront Payment from Amoytop as Pevifoscorvir Sodium Secures Breakthrough Therapy Designation in China

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapie...

July 08, 2026 | Wednesday | News
InnoCare Doses First Patient in China Trial of Novel CDH17-Targeted ADC ICP-B208

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced to...

July 07, 2026 | Tuesday | News
Insilico Medicine and Takeda Forge Up to $600 Million AI Drug Discovery Collaboratio

Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas Insilico Medicine ("Insilico" HKEX:3696), a ...

July 07, 2026 | Tuesday | News
Cornerstone Robotics Wins EU CE Mark for Sentire® Surgical System, Expanding Into European Markets

Cornerstone Robotics ("CSR"), a leading global innovator in surgical robotics based in Hong Kong, China, is pleased to announce its Sentire® Endoscop...

May 27, 2026 | Wednesday | News
Guardant Health and Manulife Partner to Launch Shield Multi-Cancer Detection Blood Test in Asia

Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and...

March 17, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close